Form 4: Cardlytics Director Clifford Sosin Reports Internal Distribution of Shares and Convertible Notes

Clifford Sosin, a Director and 10% owner of Cardlytics, Inc., reported pro rata distributions of common stock and convertible senior notes to partners of investment vehicles he manages, with no consideration exchanged.

Summary

• Clifford Sosin, a Director and 10% owner of Cardlytics, Inc. (CDLX), filed a Form 4 reporting changes in beneficial ownership.
• A pro rata distribution of 15,855 shares of Common Stock was made by Sosin Master, L.P. to its partners for no consideration.
• A pro rata distribution of $57,000 principal amount of 4.25% Convertible Senior Notes due 2029 was made by Sosin Master, L.P. to its partners for no consideration.
• Following these transactions, beneficial ownership includes 5,599,023 shares of Common Stock.
• Beneficial ownership also includes $21,243,000 principal amount of 4.25% Convertible Senior Notes due April 1, 2029.
• The Convertible Senior Notes have an initial conversion rate of 55.4939 shares of Common Stock per $1,000 principal amount, subject to adjustment.
• The Issuer has the option, at its sole discretion, to settle conversions of the Notes in cash, shares of Common Stock, or a combination, meaning the reporting person is not deemed a beneficial owner of any shares of Common Stock underlying the Notes for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.

Sentiment

Score: 5

Explanation: The Form 4 reports a pro rata distribution of shares and convertible notes by an insider to partners for no consideration, indicating an internal restructuring of holdings rather than a market-driven transaction or a change in the insider's overall beneficial interest in the company. This is generally a neutral event.

Positives

• The transaction represents an internal restructuring of holdings within investment vehicles managed by Clifford Sosin, rather than a sale for consideration, indicating no direct divestment from the company by the insider.
• Clifford Sosin maintains a substantial beneficial ownership stake in Cardlytics, Inc. through his managed entities, aligning his interests with those of other shareholders.

Negatives

• The distribution of shares and notes to partners, while not a direct sale by the insider, could potentially lead to future sales by those partners, which might create selling pressure on the stock.
• The transaction is a distribution rather than a purchase, which might otherwise be interpreted as a strong positive signal of increased confidence.

Risks

• Potential dilution risk from the 4.25% Convertible Senior Notes if Cardlytics, Inc. chooses to settle conversions in shares, although the reporting person is not deemed a beneficial owner of these underlying shares for Section 13(d) purposes.
• Future market activity by the recipients of the distributed shares and notes could introduce additional selling pressure on Cardlytics' stock.

Future Outlook

The Form 4 filing is a historical report of an insider transaction and does not contain any forward-looking statements or guidance regarding Cardlytics, Inc.'s future performance or strategic outlook.

Industry Context

This Form 4 filing details an internal restructuring of holdings by a significant insider, Clifford Sosin, within his managed investment vehicles. Such transactions are routine disclosures for insiders and typically reflect individual portfolio management decisions rather than broader industry trends or competitive shifts. The continued substantial beneficial ownership by a director and 10% owner indicates ongoing commitment to the company.

Comparison to Industry Standards

• This Form 4 filing adheres to standard SEC reporting requirements for insider transactions, ensuring transparency regarding changes in beneficial ownership.
• The reported beneficial ownership of over 5.5 million shares of common stock and $21 million in convertible senior notes by Clifford Sosin, a Director and 10% owner, represents a significant stake in Cardlytics, Inc., which is common for large institutional investors or activist shareholders.

Stakeholder Impact

• Shareholders: The distribution itself has no direct immediate impact on the company's outstanding shares or market capitalization. However, if the recipients of the distributed shares/notes decide to sell them in the future, it could create selling pressure. The continued significant beneficial ownership by Clifford Sosin (through his managed entities) indicates ongoing alignment with shareholder interests.

Key Dates

Keywords

Cardlytics, CDLX, Form 4, SEC filing, insider transaction, beneficial ownership, common stock, convertible notes, Clifford Sosin, Sosin Master, CAS Investment Partners, equity distribution